JINCY MATHEW: Open Payments
NPI 1093953648 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,645 in 46 payments from 15 companies in 2025. Trend: 2023 $575 · 2024 $2,357 · 2025 $1,645
Food & beverage: $1,645
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $344 |
| GENZYME CORPORATION | 7 | $308 |
| Janssen Biotech, Inc. | 4 | $184 |
| PFIZER INC. | 4 | $148 |
| Amgen Inc. | 1 | $126 |
| Novartis Pharmaceuticals Corporation | 5 | $107 |
| Galderma Laboratories, L.P. | 2 | $107 |
| Cipher Pharmaceuticals US LLC | 1 | $94 |
| KYOWA KIRIN, INC. | 3 | $59 |
| Organon LLC | 3 | $51 |
Products named: DUPIXENT, SKYRIZI, TREMFYA, OTEZLA, NEMLUVIO, LITFULO, Natroba, COSENTYX.
Industry payments across MI — which companies pay providers there.
